Teva is the largest manufacturer of generic drugs in the world, and we are among the world’s top 10 pharmaceutical companies.
Here in Canada, Teva makes both generic and brand-name pharmaceuticals. With over 250,000* prescriptions filled each day, we understand the shared role of brand-name and generic medications in a sustainable healthcare system.
We offer more than 400 brand and generic medications, to treat everything from ear infections to diabetes, heart disease and cancer. Because generic products are priced substantially lower than their brand equivalents, we save Canada’s healthcare system more than $15 billion annually.
At Teva Canada, we’re proud of our history, our talented people, our diverse workplace and our commitment to giving back to our communities.
Contact:
Address: 30 Novopharm Ct., Toronto, Ontario, M1B 2K9 Canada
Tel.: +1-800-268-4127
Website: https://www.tevacanada.com/Home.aspx
Doug Sommerville, senior vice-president and general manager of Teva Canada, discusses Teva Canada’s enviable top five positioning within the global organization, the strength of Teva’s generics portfolio within Canada, and…
The president & CEO of Canada’s largest generics player considers the current market dynamics for generic products, including IP regulation, generic penetration, and the advantages of balancing branded and non-branded…
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing before becoming Sales Vice President…
Mike Brogan, before taking up the mantle of President at IMS was VP of Business Integration at IMS for a year. Today, he talks about the difficulties he has come…
Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s.…
Minister for Science shares with us how the Canadian Government has taken a different approach to funding innovationand the benefits it has reaped in the pharma industry as a whole…
Gary Goodyear, Minister for Science, shares with us how the Canadian Government has taken a different approach to funding innovation and the benefits it has reaped in the pharma industry…
You have been President of Rx&D since 2004, and have witnessed the market’s development over the years. What have been the most important issues since you started and what are…
See our Cookie Privacy Policy Here
